NASDAQ: ABCM
Abcam plc
Healthcare · Biotechnology
Market Cap
$5.52B
52w High
$25.32
52w Low
$12.48
P/E
554.61
Volume
7.43M
Outstanding Shares
230.15M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 53.49% over the last year. Revenue grew 2.22% over the trailing twelve months. Operating margin moved from 8.8% to 19.74%. Free cash flow declined 92.7% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 19.74%. A decisive move in revenue — currently up 2.22% — would be the clearest signal to resolve the ambiguity.
Company profile
Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
4
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 31, 2023
Q4 FY23 · EPS est — · Revenue est —
View